Skip to search formSkip to main contentSkip to account menu

DP 155

Known as: DP-155, DP155 cpd 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Drug CombinationsIndomethacinPhosphatidylcholines
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
DP-155-1 Bilirubin酸化を指標とした心筋虚血再潅流後のOxidative stressの動態およびNitric Oxideの役割(第108回日本外科学会定期学術集会)
2008
2008
DP-155-3 活性化プロテインCは虚血再灌流心筋障害に対して内皮機能を介した保護効果を有する(第108回日本外科学会定期学術集会)
2008
2008
DP-155-6 心停止ドナー心保護の実験的検討 : Verapamil前投与およびcontrolled reperfusionで虚血障害抑制は可能か(第108回日本外科学会定期学術集会)
2008
2008
DP-155-2 ウサギ冠虚血再灌流モデルにおけるG-CSF皮下投与大網充填術の左室機能改善効果(第108回日本外科学会定期学術集会)
2007
2007
DP-155-3 当院におけるDirect Kugel法278症例の経験(第107回日本外科学会定期学術集会)
2007
2007
DP-155-2 両側および多発ヘルニアに対する腹腔鏡下ヘルニア修復術の検討(第107回日本外科学会定期学術集会)
2006
2006
A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl…
Indomethacin has been suggested for the treatment of Alzheimer's disease (AD), but its use is limited by gastrointestinal and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)